A personalized medicine company specializing in genetic and epigenetic analyses to integrate genomics-based diagnostics into medical practice (polygenic risk analyses, pharmacogenetic tests, epigenetic age assessments).
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| not disclosed | Jan, 2026 | unspecified |
Industries
Frequently Asked Questions
Where is Permedio located?
Permedio is located in Neunkirchen, Austria.
What industries does Permedio operate in?
Permedio operates in the following industries: personalized medicine, genetics, epigenetics, biotechnology, healthcare.
When was Permedio founded?
Permedio was founded on 2026-01-20.
Who are the investors in Permedio?
The investors in Permedio are: Hans Peter Haselsteiner (via ZMH GmbH).
Who are the founders of Permedio?
The founders of Permedio are: Stefan Wöhrer, Katharina Schneider.
What specific types of genetic analysis does Permedio perform?
Permedio specializes in pharmacogenetics, which studies how genes influence drug response, as well as comprehensive preventive diagnostics to identify hereditary risks for various health conditions.
How does Permedio support patients through the testing process?
The center offers professional genetic counseling both before and after testing to ensure patients fully understand their results and the implications for their personalized medical care.
What makes Permedio's approach to medicine unique?
Permedio focuses on personalized medicine, moving away from a one-size-fits-all approach by using individual genetic profiles to tailor prevention and therapy specifically to each patient.
Can Permedio's tests help reduce the risk of adverse drug reactions?
Yes, by identifying genetic variations that affect metabolism, their pharmacogenetic tests help clinicians avoid prescribing medications that could cause harmful reactions or be ineffective for a specific patient.
Does Permedio offer consultations for healthy individuals?
Absolutely. Their preventive diagnostic services are designed for healthy individuals who wish to proactively manage their health by understanding their genetic predisposition to certain diseases.